Search research articles
Contact Us
Filters
Showing results (11-20 of 81) with videos related to
Page
of 9
Sort By:
The Lancet. Oncology
|
March 9, 2017
Genomic-adjusted radiation dose
Daniel E Spratt, Daniel R Wahl, Theodore S Lawrence
Trends in Biochemical Sciences
|
November 9, 2019
Running the Light: Nucleotide Metabolism Drives Bypass of Senescence in Cancer
Christopher J Halbrook, Daniel R Wahl, Costas A Lyssiotis
Cancer Journal (Sudbury, Mass.)
|
September 27, 2021
Clinical Targeting of Altered Metabolism in High-Grade Glioma
Andrew J Scott, Costas A Lyssiotis, Daniel R Wahl
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 22, 2016
Reply to Yang et al and De Bari et al
Daniel R Wahl, Yebin Tao, Matthew Schipper, et al.
Neoplasia (New York, N.Y.)
|
February 1, 2023
Developing H3K27M mutant selective radiosensitization strategies in diffuse intrinsic pontine glioma
Leslie A Parsels, Daniel R Wahl, Carl Koschmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 28, 2018
Casual Causality: Does Radiofrequency Ablation Really Prolong Survival After Treatment of Localized Hepatocellular Carcinoma?
Daniel R Wahl, Matthew J Schipper, Neehar D Parikh, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 27, 2009
Apoptotic signaling activated by modulation of the F0F1-ATPase: implications for selective killing of autoimmune lymphocytes
Thomas B Sundberg, Lara Swenson, Daniel R Wahl, et al.
Frontiers in Oncology
|
August 2, 2021
Survival Prediction Analysis in Glioblastoma With Diffusion Kurtosis Imaging
Yuan Li, Michelle M Kim, Daniel R Wahl, et al.
Immunological Reviews
|
August 15, 2012
Distinct metabolic programs in activated T cells: opportunities for selective immunomodulation
Daniel R Wahl, Craig A Byersdorfer, James L M Ferrara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 3, 2015
Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma
Daniel R Wahl, Matthew H Stenmark, Yebin Tao, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 81) with videos related to
Sort By:
Page
of 9
The Lancet. Oncology
|
March 9, 2017
Genomic-adjusted radiation dose
Daniel E Spratt, Daniel R Wahl, Theodore S Lawrence
Trends in Biochemical Sciences
|
November 9, 2019
Running the Light: Nucleotide Metabolism Drives Bypass of Senescence in Cancer
Christopher J Halbrook, Daniel R Wahl, Costas A Lyssiotis
Cancer Journal (Sudbury, Mass.)
|
September 27, 2021
Clinical Targeting of Altered Metabolism in High-Grade Glioma
Andrew J Scott, Costas A Lyssiotis, Daniel R Wahl
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 22, 2016
Reply to Yang et al and De Bari et al
Daniel R Wahl, Yebin Tao, Matthew Schipper, et al.
Neoplasia (New York, N.Y.)
|
February 1, 2023
Developing H3K27M mutant selective radiosensitization strategies in diffuse intrinsic pontine glioma
Leslie A Parsels, Daniel R Wahl, Carl Koschmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 28, 2018
Casual Causality: Does Radiofrequency Ablation Really Prolong Survival After Treatment of Localized Hepatocellular Carcinoma?
Daniel R Wahl, Matthew J Schipper, Neehar D Parikh, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 27, 2009
Apoptotic signaling activated by modulation of the F0F1-ATPase: implications for selective killing of autoimmune lymphocytes
Thomas B Sundberg, Lara Swenson, Daniel R Wahl, et al.
Frontiers in Oncology
|
August 2, 2021
Survival Prediction Analysis in Glioblastoma With Diffusion Kurtosis Imaging
Yuan Li, Michelle M Kim, Daniel R Wahl, et al.
Immunological Reviews
|
August 15, 2012
Distinct metabolic programs in activated T cells: opportunities for selective immunomodulation
Daniel R Wahl, Craig A Byersdorfer, James L M Ferrara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 3, 2015
Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma
Daniel R Wahl, Matthew H Stenmark, Yebin Tao, et al.
Page
of 9